|
Study measures |
||
| (N = 20) |
||
|
|
||
| n |
(%) |
|
| 1. Was the study valid? |
||
| Yes |
15 |
(75) |
| No |
5 |
(25) |
| 2. Was the study funded by a pharmaceutical company? |
||
| Yes |
16 |
(80) |
| No |
1 |
(5) |
| Unknown |
3 |
(15) |
| 3. What was the study outcome? |
||
| Patient-oriented |
12 |
(60) |
| Disease-oriented |
8 |
(40) |
| 4. What was the study therapy compared to? |
||
| Another medication or therapy |
8 |
(40) |
| Placebo |
10 |
(50) |
| Neither |
2 |
(10) |
| 5. Was a graphic* used on the brochure? |
||
| Yes |
19 |
(95) |
| No |
1 |
(5) |
| 6. Of the brochures with graphics, how was the data presented? |
||
| Relative risk reduction |
4 |
(21) |
| Absolute risk reduction |
1 |
(5) |
| Other** |
14 |
(74) |
| 7. Was the outcome of interest statistically significant?*** |
||
| Yes |
19 |
(95) |
| No |
1 |
(5) |
| 8. Did the data on the brochure differ from the underlying study? |
||
| Yes |
3 |
(15) |
| No |
17 |
(85) |
|
*Includes bar charts, line graphs, pie charts, arrows **Includes mean change, point differences, etc ***p < 0.05 | ||
Cardarelli et al. BMC Family Practice 2006 7:13 doi:10.1186/1471-2296-7-13 |
||